Updates

Ellele Health recently took part in the Edinburgh Endometrial Cancer Study Day, a collaborative forum led by Ellele’s Chief Medical Officer Neil Ryan, bringing together experts from healthcare, research, and industry to explore the development of an end-to-end model of care for endometrial cancer in Scotland. Continue reading…

Origin Sciences are proud to announce the launch of our groundbreaking TRIOMIC study in partnership with The Shrewsbury and Telford Hospital NHS Trust. Continue reading…

On 4th September, the Royal Institution in London hosted our inaugural Collaborate Conference. Continue reading…

Following a successful Ellele-01 study, Ellele Health was established in July 2024 as a wholly owned subsidiary of The Origin Group Limited (TOGL), marking an exciting new chapter in advancing women’s health diagnostics. Continue reading…

Ellele Sampling Device is a novel vaginal sampling device designed to collect a richer and more representative vaginal sample, while preserving the comfort of patients. Origin Sciences has launched Ellele-01, the first clinical research study evaluating the Ellele Sampling Device, marking an important milestone in the development of the technology. Continue reading…